Hyacinth Empinado/STAT For biotech companies, 2020 could have been a lot worse than it was, all things considered. More than most other businesses, small, early-stage biotech startups were better placed to dodge some of the pandemic’s immediate consequences. When state governments issued stay-at-home orders, many declared that biotech scientists and technicians were essential workers and could continue to go into their labs. Companies...
Read Full StoryTop News
Related
Disease-prevention-and-treatment
Central Shenandoah Health District says may be at least March before Phase 1b vaccination complete
, 6min
0
Disease-prevention-and-treatment
Editorial: When recovery houses fail, so does addiction recovery
, 8min
0